By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Bupropion

Bupropion

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
6 Min Read
SHARE
4 min read|729 words

Bupropion Drug Profile

What is Bupropion?

Bupropion is an atypical antidepressant medication that belongs to the class of norepinephrine-dopamine reuptake inhibitors (NDRI). It is primarily prescribed for treating major depressive disorder and as a smoking cessation aid. Unlike many other antidepressants, bupropion does not affect serotonin levels and has a unique mechanism of action that makes it useful for multiple conditions.

Uses

Bupropion has several FDA-approved and well-documented uses:

Major Depressive Disorder: The primary indication for bupropion is treating depression, particularly in patients who may not respond well to selective serotonin reuptake inhibitors (SSRIs) or who experience sexual side effects from other antidepressants.

Smoking Cessation: Bupropion is widely used as a smoking cessation aid, helping reduce nicotine cravings and withdrawal symptoms when quitting tobacco.

Submit Your Paper
GMJ_Submit_Banner

Seasonal Affective Disorder: Extended-release formulations are approved for preventing seasonal affective disorder in patients with a history of this condition.

Attention Deficit Hyperactivity Disorder (ADHD): While not FDA-approved for this use, bupropion is sometimes prescribed off-label for ADHD, particularly in adults.

Weight Management: In combination with naltrexone, bupropion is approved for chronic weight management in obese or overweight adults with weight-related health conditions.

How it works

Bupropion works by blocking the reuptake of two key neurotransmitters in the brain: norepinephrine and dopamine. This action increases the availability of these chemicals in brain synapses, which helps improve mood and reduce cravings. Unlike most other antidepressants, bupropion does not significantly affect serotonin levels, which explains why it has a different side effect profile and may be effective when other antidepressants are not.

Side effects

Common side effects include:

  • Dry mouth
  • Nausea and vomiting
  • Constipation
  • Dizziness
  • Headache
  • Insomnia or sleep disturbances
  • Tremor
  • Weight loss

Serious side effects to watch for:

  • Seizures (especially at higher doses)
  • Suicidal thoughts or behaviors, particularly in young adults
  • Severe allergic reactions with rash or swelling
  • High blood pressure
  • Angle-closure glaucoma

Warnings and precautions

Several important safety considerations apply to bupropion use:

Seizure Risk: Bupropion lowers the seizure threshold and should be avoided in patients with seizure disorders, eating disorders, or those undergoing abrupt alcohol or sedative withdrawal.

Mental Health Monitoring: Like all antidepressants, bupropion carries a black box warning for increased suicide risk in children, adolescents, and young adults under 25, requiring close monitoring especially during initial treatment.

Pregnancy and Breastfeeding: Bupropion is classified as pregnancy category C, meaning risks cannot be ruled out. The medication passes into breast milk and should be used with caution in nursing mothers.

Liver and Kidney Function: Dose adjustments may be necessary in patients with hepatic or renal impairment, as the drug is metabolized by the liver and eliminated through the kidneys.

Cardiovascular Considerations: Bupropion can increase blood pressure and heart rate, requiring monitoring in patients with cardiovascular disease.

Interactions

Bupropion has several significant drug interactions:

Monoamine Oxidase Inhibitors (MAOIs): Concurrent use is contraindicated due to risk of hypertensive crisis; allow at least 14 days between discontinuing MAOIs and starting bupropion.

Other medications containing bupropion: Avoid duplicate therapy as this increases seizure risk and potential for overdose.

Medications that lower seizure threshold: Antipsychotics, tricyclic antidepressants, and tramadol may increase seizure risk when combined with bupropion.

CYP2D6 substrates: Bupropion inhibits this enzyme, potentially increasing levels of medications like metoprolol, paroxetine, and desipramine.

Warfarin: Bupropion may affect warfarin metabolism, requiring closer monitoring of INR levels.

Alcohol: Increases seizure risk and should be avoided or used with extreme caution.

Nicotine replacement therapy: May increase blood pressure when used together for smoking cessation.

Levodopa: Increased risk of adverse effects when used concurrently.

Check interactions with the GMJ Interaction Checker

Dosage

For depression, the typical starting dose is 100 mg twice daily for immediate-release tablets, or 150 mg once daily for extended-release formulations. The dose may be gradually increased to a maximum of 450 mg daily, divided into multiple doses, with no single dose exceeding 150 mg for immediate-release tablets.

For smoking cessation, treatment typically begins with 150 mg daily for three days, then increases to 150 mg twice daily for 7-12 weeks. Treatment should start 1-2 weeks before the planned quit date.

Dosage adjustments are necessary for patients with liver or kidney impairment. All dosage decisions should be made by a healthcare provider based on individual patient factors and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Bupropion." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/bupropion/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Bidi Smoking Linked to Elevated Cancer Risk in Large Indian Study
In the news
  • Bidi Smoking Linked to Elevated Cancer Risk in Large Indian Study · Jul 9, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Magnesium’s hidden role in insulin signalling: why the mineral matters for glucose control

Magnesium acts as a critical molecular switch in insulin signalling. New analysis…

Why the same bread raises blood sugar differently in different people

Researchers at the Weizmann Institute found that identical carbohydrate meals produce glucose…

Vitamin D dose response is not linear: Why shelf-picked supplements may not work as expected

Vitamin D supplements do not work the same way for everyone. Research…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Iodine supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Magnesium supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Carbamazepine

By
Prof. Giorgi Pkhakadze
02/06/2026

Copper supplements

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up